Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

PowerPoint Presentation 1 CONFIDENTIAL – Contains proprietary information. Not intended for external distribution. Optimizing Professional Wellness: Navigating Workplace Experiences in Healthcare Ishwaria M. Subbiah, M.D., M.S. Executive Director, Cancer Care Equity and Professional Wellness, SCRI Medical Director, Supportive Care Oncology, Health Equity, and Professional Well-being …
MGUS – Monoclonal Gammopathy of Undetermined Significance Gastrointestinal Breakthroughs: Recent Progress in Research and Practice Thomas Reske, MD PhD CMD FACP AGSF Associate Professor Of Medicine LSU HSC New Orleans and SLVHCS 1 Disclosure I do not have any commercial or financial relationship to any topics or products discussed. A commercial interest …
The Transformative Role of Nurse Navigators in Patient Experience and Care The Transformative Role of Nurse Navigators in Patient Experience and Care STEPHANIE BONFILIO, MSN, RN, OCN, ONN-CG Nothing to disclose The History of Oncology Navigation 1990: Harold Freeman, MD launched the first navigation program in Harlem, NY 2005: navigation received …
Pathologic Differences in Patients with Breast Cancer at BMC Project Background, Hypothesis and Design What’s Happening in Breast Cancer Michelle Loch, MD LSU Health Sciences Center April 19, 2024 Objectives • Review advances in breast cancer in 2023 • Early breast cancer • Survivorship • Metastatic Breast Cancer • On the horizon Early Breast Cancer …
LOS_Krane_ProstateCa.pptx Improving Outcomes in Clinically Localized Prostate Cancer L Spencer Krane MD FACS Chief of Urology, Southeastern Louisiana Veterans Healthcare System Disclosures • Paid Consultant • HIFU Prostate Services • Angiodynamics • Exact Sciences • Sonablate What Are Patients Reading? HOW DOES TREATMENT EFFECT PATIENTS? …
Updates in Kidney and Bladder Cancers: Where we are with Immunotherapy and Precision Medicine? Bladder Cancer: An Update on Systemic Therapies and Precision Oncology April 19, 2024 LOS 4th Annual Louisiana Cancer Congress Karine Tawagi, MD Assistant Professor of Medicine, Division of Hematology/Oncology, Genitourinary Oncology | UIC Acting Program Director, Division of …
PowerPoint Presentation Diagnosis and Treatment of Leptomeningeal Disease – Where are we in 2024? Isabella C. Glitza Oliva, MD, PhD Associate Professor Director of the Melanoma Medical Oncology LMD Program University of Texas MD Anderson Cancer Center, Houston, Texas, USA Disclosures Speaker/Consultant: Pfizer, Novartis, Biodexa, Everclear( Advisory Board: Bristol …
Update on Palliative Care Quality of Life Matters: Exploring Palliative Care Principles in 2024 JIMMY ELLIS, MD MEDICAL DIRECTOR OF PALLIATIVE CARE TOURO INFIRMARY NEW ORLEANS Disclosures  Speakers Bureau: AstraZeneca  Medical Director: Concerned Care Home Health, Palliative Care and Hospice Definitions PALLIATIVE CARE HOSPICE TREATMENT WITH PALLIATIVE …
Addressing this issue required a coordinated, multidisciplinary approach that involved engaging the cancer center leadership across 3 treatment departments—medical, radiation, and surgical oncology—administration, physicians, advanced practice providers (APPs), patient navigation, genetic counseling, scheduling, imaging, lab, and pathology. The primary goals of the initiative were to transform …
May 3, 2024
Experience the forefront of oncological advancements this May in Seattle, as esteemed experts from across the state converge to provide insights into the latest clinical updates. Uncover emerging changes in the diagnosis and care of patients with specific disease types and seize the boundless networking opportunities available. Save the date and secure your complimentary spot now! PROVIDER REGISTRATION …
RMOS 2024 Spring Conference Wednesday May 8, 2024 Grand Hyatt Denver Denver, CO Attendee Roster First Name Last Name Title Account Name Brenda Holcomb Manager AbbVie Inc. Janet Lucero Oncology Account Executive AbbVie Inc. Karen Wilson MN, RN, CGRN, CTTS AdventHealth Parker Anna Pugh President AGP Strategies Carla Apodaca Executive Oncology Account Specialist AstraZeneca …
BMT and Rehab CAR-T and Rehab Comprehensive Care of the Bone Marrow Transplant Patient Macy Hogan, PT, DPT Franciscan Health Objectives • To address special considerations for BMT patients to improve awareness, clinical reasoning, and standard of care when treating a BMT patient, particularly patients undergoing CAR-T therapy • To improve awareness of changes in the …
Bladder Sparing Therapies for Urothelial Cancer: A Radiation Oncolgist’s Perspective BLADDER SPARING THERAPIES FOR UROTHELIAL CANCER: A RADIATION ONCOLOGIST’S PERSPECTIVE MINNESOTA SOCIETY OF CLINICAL ONCOLOGY 2024 SPRING CONFERENCE, 04/24/2024 OUTLINE • INTRODUCTION • WORKUP, STAGING • DEFINITIVE MANAGEMENT OPTIONS • BLADDER PRESERVATION PRINCIPLES • CASES AND CONTROVERSIES …
Fecal Microbiota Transplantation in Allogeneic Stem Cell Transplantation, Acute Myeloid Leukemia, and Acute Graft-Versus-Host Disease Fecal Microbiota Transplantation in Allogeneic Stem Cell Transplantation, Acute Myeloid Leukemia, and Acute Graft-Versus-Host Disease David Kazadi, MD, PhD Fellow - Department of Medicine, Division of Hematology, Oncology, and Transplantation Minnesota …
Hitting the Target: Selecting Patients for Targeted Therapy in Metastatic Urothelial Cancer Arlene Siefker-Radtke, MD Professor Department of Genitourinary Medical Oncology Perioperative Therapy in Surgically Resectable Urothelial Carcinoma DISCLOSURE INFORMATION Arlene Siefker-Radtke, MD Advisory Boards: Abbvie, Astellas, AstraZeneca, Basilea, Bicycle Therapeutics, Bristol …
Introduction to CAR-T Therapy Introduction to CAR T-Cell Therapy Agenda • Objectives • Introduction to chimeric antigen receptor T (CAR T)–cell therapy • Current CAR T-cell products and clinical trials • CAR T-cell therapy availability • CAR T-cell treatment process • Common adverse events associated with CAR T-cell therapy • Conclusions 1 Objectives ● Review …
T1 High-grade Bladder Cancer: Contemporary Management and Outcomes HIGH RISK NMIBC: STATE OF THE ART 1 ASHISH M. KAMAT, MD, MBBS PROFESSOR OF UROLOGIC ONCOLOGY WAYNE B. DUDDLESTEN PROFESSOR OF CANCER RESEARCH DIRECTOR, BLADDER CANCER RESEARCH PRESIDENT, INTERNATIONAL BLADDER CANCER GROUP (IBCG) Ashish M. Kamat, MD 3 DEFINITION OF HIGH RISK Ashish M. Kamat, MD …
The Affordable Connectivity Program ends today, leaving 1 in 6 American households without access to high-speed internet.
Improving timely identification and referral of patients who may be eligible for chimeric antigen receptor (CAR) T-cell therapy is critical for improving outcomes for patients with hematologic malignancies. On February 7, 2024, ACCC hosted a virtual Working Summit: Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education to explore topics including patient and caregiver needs …